Blueberries And Strawberries To Reduce The Risk Of Heart Attack.
Eating three or more servings of blueberries and strawberries each week may aid slash a woman's gamble of heart attack, a large new study suggests. The study included nearly 94000 unfledged and middle-aged women who took part in the Nurses' Health Study II. The women completed questionnaires about their chamber every four years for 18 years. During the on period, 405 participants had heart attacks. Women who ate the most blueberries and strawberries were 32 percent less fitting to have a heart attack, compared to women who ate berries once a month or less.
This held firm even among women who ate a diet rich in other fruits and vegetables. This help was independent of other heart risk factors such as advancing age, high blood pressure, kind history of heart attack, body mass index, exercise, smoking, and caffeine and hard stuff intake. The findings appear online Jan 14, 2013 in the journal Circulation.
The learning can't say specifically what about the berries seemed to result in a lower risk of heart offensive among these women, or that there was a direct cause-and-effect link between eating the berries and lowered heart denigrate risk. But blueberries and strawberries contain high levels of compounds that may help add to arteries, which counters plaque buildup, the researchers said.
Heart attacks can occur when plaque blocks blood go to the heart. "Berries were the most commonly consumed sources of these substances in the US diet, and they are one of the best sources of these resilient bioactive compounds," said study lead author Aedin Cassidy. "These substances, called anthocyanins - a flavonoid - are unpretentiously present in red- and blue-colored fruits and vegetables, so they are also found in momentous amounts in cherries, grapes, eggplant, black currants, plums and other berries".
Saturday 30 August 2014
Tuesday 26 August 2014
Women Suffering From Depression And Diabetes Have A Higher Risk Of Death
Women Suffering From Depression And Diabetes Have A Higher Risk Of Death.
Women distress from both diabetes and sadness have a greater risk of dying, especially from resolution disease, a new study suggests. In fact, women with both conditions have a twofold increased jeopardy of death, researchers say. "People with both conditions are at very high risk of death," said prima donna researcher Dr Frank B Hu, a professor of medicine at Harvard Medical School. "Those are facsimile whammies".
When people are afflicted by both diseases, these conditions can starring role to a "vicious cycle," Hu said. "People with diabetes are more likely to be depressed, because they are under long-term psychosocial stress, which is associated with diabetes complications". People with diabetes who are depressed are less reasonable to take attention of themselves and effectively manage their diabetes, he added. "That can lead to complications, which increase the risk of mortality".
Hu stressed that it is powerful to manage both the diabetes and the depression to lower the mortality risk. "It is reachable that these two conditions not only influence each other biologically, but also behaviorally," he said. Type 2 diabetes and cavity are often related to unhealthy lifestyles, including smoking, poor diet and lack of exercise, according to the researchers.
In addition, impression may trigger changes in the nervous system that adversely affect the heart, they said. The announce is published in the January issue of the Archives of General Psychiatry.
Commenting on the study, Dr Luigi Meneghini, an secondary professor of clinical medicine and director of the Eleanor and Joseph Kosow Diabetes Treatment Center at the Diabetes Research Institute of the University of Miami Miller School of Medicine, said the findings were not surprising. "The retreat highlights that there is a unblemished increase in jeopardize to your health and to your life when you have a combination of diabetes and depression," he said.
Women distress from both diabetes and sadness have a greater risk of dying, especially from resolution disease, a new study suggests. In fact, women with both conditions have a twofold increased jeopardy of death, researchers say. "People with both conditions are at very high risk of death," said prima donna researcher Dr Frank B Hu, a professor of medicine at Harvard Medical School. "Those are facsimile whammies".
When people are afflicted by both diseases, these conditions can starring role to a "vicious cycle," Hu said. "People with diabetes are more likely to be depressed, because they are under long-term psychosocial stress, which is associated with diabetes complications". People with diabetes who are depressed are less reasonable to take attention of themselves and effectively manage their diabetes, he added. "That can lead to complications, which increase the risk of mortality".
Hu stressed that it is powerful to manage both the diabetes and the depression to lower the mortality risk. "It is reachable that these two conditions not only influence each other biologically, but also behaviorally," he said. Type 2 diabetes and cavity are often related to unhealthy lifestyles, including smoking, poor diet and lack of exercise, according to the researchers.
In addition, impression may trigger changes in the nervous system that adversely affect the heart, they said. The announce is published in the January issue of the Archives of General Psychiatry.
Commenting on the study, Dr Luigi Meneghini, an secondary professor of clinical medicine and director of the Eleanor and Joseph Kosow Diabetes Treatment Center at the Diabetes Research Institute of the University of Miami Miller School of Medicine, said the findings were not surprising. "The retreat highlights that there is a unblemished increase in jeopardize to your health and to your life when you have a combination of diabetes and depression," he said.
Friday 22 August 2014
Symptoms Of A Concussion For Boys And Girls Are Different
Symptoms Of A Concussion For Boys And Girls Are Different.
Among high-class day-school athletes, girls who suffer concussions may have different symptoms than boys, a green study finds. The findings suggest that boys are more likely to report amnesia and confusion/disorientation, whereas girls disposed to report drowsiness and greater sensitivity to noise more often. "The take-home implication is that coaches, parents, athletic trainers, and physicians must be observant for all signs and symptoms of concussion, and should do homage that young male and female athletes may present with different symptoms," said R Dawn Comstock, an initiator of the study and an associate professor of pediatrics at the Ohio State University College of Medicine in Columbus.
The findings are slated to be presented Tuesday at the National Athletic Trainers' Association's (NATA) assistant Youth Sports Safety Summit in Washington, DC. More than 60000 leader injuries crop up among high school athletes every year, according to the US Centers for Disease Control and Prevention. Although more males than females participate in sports, female athletes are more inclined to to withstand sports-related concussions, the researchers note. For instance, girls who tomfoolery high school soccer suffer almost 40 percent more concussions than their manful counterparts, according to NATA.
The findings suggest that girls who suffer concussions might sometimes go undiagnosed since symptoms such as drowsiness or warmth to noise "may be overlooked on sideline assessments or they may be attributed to other conditions," Comstock said. For the study, Comstock and her co-authors at the University of Virginia, Charlottesville, and the University of California, Santa Barbara, examined statistics from an Internet-based observation system for high school sports-related injuries. The researchers looked at concussions active in interscholastic sports practice or meet in nine sports (boys' football, soccer, basketball, wrestling and baseball and girls' soccer, volleyball, basketball and softball) during the 2005-2006 and 2006-2007 shape years at a representative sample of 100 drugged schools. During that time, 812 concussions (610 in boys and 202 in girls) were reported.
In adding to noting the prevalence of each reported symptom among males and females, the researchers compared the unalloyed number of symptoms, the time it took for symptoms to resolve, and how soon the athletes were allowed to earn to play. Based on previous studies, the researchers thought that girls would report more concussion symptoms, would have to delay longer for symptoms to resolve, and would take longer to return to play. However, there was no gender imbalance in those three areas.
Among high-class day-school athletes, girls who suffer concussions may have different symptoms than boys, a green study finds. The findings suggest that boys are more likely to report amnesia and confusion/disorientation, whereas girls disposed to report drowsiness and greater sensitivity to noise more often. "The take-home implication is that coaches, parents, athletic trainers, and physicians must be observant for all signs and symptoms of concussion, and should do homage that young male and female athletes may present with different symptoms," said R Dawn Comstock, an initiator of the study and an associate professor of pediatrics at the Ohio State University College of Medicine in Columbus.
The findings are slated to be presented Tuesday at the National Athletic Trainers' Association's (NATA) assistant Youth Sports Safety Summit in Washington, DC. More than 60000 leader injuries crop up among high school athletes every year, according to the US Centers for Disease Control and Prevention. Although more males than females participate in sports, female athletes are more inclined to to withstand sports-related concussions, the researchers note. For instance, girls who tomfoolery high school soccer suffer almost 40 percent more concussions than their manful counterparts, according to NATA.
The findings suggest that girls who suffer concussions might sometimes go undiagnosed since symptoms such as drowsiness or warmth to noise "may be overlooked on sideline assessments or they may be attributed to other conditions," Comstock said. For the study, Comstock and her co-authors at the University of Virginia, Charlottesville, and the University of California, Santa Barbara, examined statistics from an Internet-based observation system for high school sports-related injuries. The researchers looked at concussions active in interscholastic sports practice or meet in nine sports (boys' football, soccer, basketball, wrestling and baseball and girls' soccer, volleyball, basketball and softball) during the 2005-2006 and 2006-2007 shape years at a representative sample of 100 drugged schools. During that time, 812 concussions (610 in boys and 202 in girls) were reported.
In adding to noting the prevalence of each reported symptom among males and females, the researchers compared the unalloyed number of symptoms, the time it took for symptoms to resolve, and how soon the athletes were allowed to earn to play. Based on previous studies, the researchers thought that girls would report more concussion symptoms, would have to delay longer for symptoms to resolve, and would take longer to return to play. However, there was no gender imbalance in those three areas.
Sunday 17 August 2014
The Gene Responsible For Alzheimer's Disease
The Gene Responsible For Alzheimer's Disease.
Data that details every gene in the DNA of 410 settle with Alzheimer's plague can now be studied by researchers, the US National Institutes of Health announced this week. This leading batch of genetic data is now available from the Alzheimer's Disease Sequencing Project, launched in February 2012 as portion of an intensified national application to find ways to prevent and treat Alzheimer's disease. Genome sequencing outlines the instruction of all 3 billion chemical letters in an individual's DNA, which is the entire set of genetic data every individual carries in every cell.
And "Providing raw DNA sequence data to a wide range of researchers is a powerful, crowd-sourced mode to find genomic changes that put us at increased risk for this devastating disease," NIH Director Dr Francis Collins said in an introduce news release. "The genome launch is designed to identify genetic risks for late onset of Alzheimer's disease, but it could also perceive versions of genes that protect us," Collins said.
Data that details every gene in the DNA of 410 settle with Alzheimer's plague can now be studied by researchers, the US National Institutes of Health announced this week. This leading batch of genetic data is now available from the Alzheimer's Disease Sequencing Project, launched in February 2012 as portion of an intensified national application to find ways to prevent and treat Alzheimer's disease. Genome sequencing outlines the instruction of all 3 billion chemical letters in an individual's DNA, which is the entire set of genetic data every individual carries in every cell.
And "Providing raw DNA sequence data to a wide range of researchers is a powerful, crowd-sourced mode to find genomic changes that put us at increased risk for this devastating disease," NIH Director Dr Francis Collins said in an introduce news release. "The genome launch is designed to identify genetic risks for late onset of Alzheimer's disease, but it could also perceive versions of genes that protect us," Collins said.
Wednesday 13 August 2014
Cardiologists Recommend The Use Of Heart Rate Monitors
Cardiologists Recommend The Use Of Heart Rate Monitors.
A everywhere employed type of heart monitor may provide a simple way to predict a person's gamble for a common heart rhythm disorder called atrial fibrillation, according to a new look at Dec 2013. Researchers found that people who have a greater number of heart contractions called inopportune atrial contractions have a substantially higher risk for atrial fibrillation. These types of contractions can be detected by a 24-hour Holter monitor.
Premature atrial contractions are impulsive heartbeats that occur in the two higher chambers of the heart. A Holter monitor is a portable device that continuously monitors the electrical interest of a person's heart. The study included 1260 people, old 65 and older, who had not been diagnosed with atrial fibrillation and underwent 24-hour Holter monitoring.
A everywhere employed type of heart monitor may provide a simple way to predict a person's gamble for a common heart rhythm disorder called atrial fibrillation, according to a new look at Dec 2013. Researchers found that people who have a greater number of heart contractions called inopportune atrial contractions have a substantially higher risk for atrial fibrillation. These types of contractions can be detected by a 24-hour Holter monitor.
Premature atrial contractions are impulsive heartbeats that occur in the two higher chambers of the heart. A Holter monitor is a portable device that continuously monitors the electrical interest of a person's heart. The study included 1260 people, old 65 and older, who had not been diagnosed with atrial fibrillation and underwent 24-hour Holter monitoring.
Sunday 3 August 2014
New Blood Thinner Pill For Patients With Deep Vein Thrombosis
New Blood Thinner Pill For Patients With Deep Vein Thrombosis.
A experimental anti-clotting pill, rivaroxaban (Xarelto), may be an effective, within and safer healing for patients coping with deep-vein thrombosis (DVT), a pair of new studies indicate. According to the research, published online Dec 4, 2010 in the New England Journal of Medicine, the deaden could sell a new option for these potentially life-threatening clots, which most typically mode in the lower leg or thigh. The findings are also slated for presentation Saturday at the annual joining of the American Society of Hematology (ASH), in Orlando, Fla.
And "These study outcomes may maybe change the way that patients with DVT are treated," study author Dr Harry R Buller, a professor of prescription at the Academic Medical Center at the University of Amsterdam, said in an ASH announcement release. "This new treatment regimen of oral rivaroxaban can potentially come to blood clot therapy easier than the current standard treatment for both the patient and the physician, with a single-drug and honest fixed-dose approach".
Another heart expert agreed. "Rivaroxiban is at least as effective as the older treat warfarin and seems safer. It is also far easier to use since it does not require blood testing to mediate the dose," said cardiologist Dr Alan Kadish, currently president of Touro College in New York City.
The about was funded in part by Bayer Schering Pharma, which markets rivaroxaban maximum the United States. Funding also came from Ortho-McNeil, which will market the drug in the United States should it pick up US Food and Drug Administration approval. In March 2009, an FDA admonitory panel recommended the drug be approved, but agency review is ongoing pending further study.
The authors note that upwards of 2 million Americans wisdom a DVT each year. These lap clots - sometimes called "economy flight syndrome" since they've been associated with the immobilization of large flights - can migrate to the lungs to form potentially deadly pulmonary embolisms. The in vogue standard of care typically involves treatment with relatively well-known anti-coagulant medications, such as the viva voce medication warfarin (Coumadin) and/or the injected medication heparin.
While effective, in some patients these drugs can stir unstable responses, as well as problematic interactions with other medications. For warfarin in particular, the possibility also exists for the development of severe and life-threatening bleeding. Use of these drugs, therefore, requires consuming and continuous monitoring. The search for a safer and easier to administer curing option led Buller's team to analyze two sets of data: One that corroded rivaroxaban against the standard anti-clotting drug enoxaparin (a heparin-type medication), and the second which compared rivaroxaban with a placebo.
A experimental anti-clotting pill, rivaroxaban (Xarelto), may be an effective, within and safer healing for patients coping with deep-vein thrombosis (DVT), a pair of new studies indicate. According to the research, published online Dec 4, 2010 in the New England Journal of Medicine, the deaden could sell a new option for these potentially life-threatening clots, which most typically mode in the lower leg or thigh. The findings are also slated for presentation Saturday at the annual joining of the American Society of Hematology (ASH), in Orlando, Fla.
And "These study outcomes may maybe change the way that patients with DVT are treated," study author Dr Harry R Buller, a professor of prescription at the Academic Medical Center at the University of Amsterdam, said in an ASH announcement release. "This new treatment regimen of oral rivaroxaban can potentially come to blood clot therapy easier than the current standard treatment for both the patient and the physician, with a single-drug and honest fixed-dose approach".
Another heart expert agreed. "Rivaroxiban is at least as effective as the older treat warfarin and seems safer. It is also far easier to use since it does not require blood testing to mediate the dose," said cardiologist Dr Alan Kadish, currently president of Touro College in New York City.
The about was funded in part by Bayer Schering Pharma, which markets rivaroxaban maximum the United States. Funding also came from Ortho-McNeil, which will market the drug in the United States should it pick up US Food and Drug Administration approval. In March 2009, an FDA admonitory panel recommended the drug be approved, but agency review is ongoing pending further study.
The authors note that upwards of 2 million Americans wisdom a DVT each year. These lap clots - sometimes called "economy flight syndrome" since they've been associated with the immobilization of large flights - can migrate to the lungs to form potentially deadly pulmonary embolisms. The in vogue standard of care typically involves treatment with relatively well-known anti-coagulant medications, such as the viva voce medication warfarin (Coumadin) and/or the injected medication heparin.
While effective, in some patients these drugs can stir unstable responses, as well as problematic interactions with other medications. For warfarin in particular, the possibility also exists for the development of severe and life-threatening bleeding. Use of these drugs, therefore, requires consuming and continuous monitoring. The search for a safer and easier to administer curing option led Buller's team to analyze two sets of data: One that corroded rivaroxaban against the standard anti-clotting drug enoxaparin (a heparin-type medication), and the second which compared rivaroxaban with a placebo.
Subscribe to:
Posts (Atom)